This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Biomarin Pharmaceutical Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Silvia Ramirez: Innovator in Liver Targeting Gene Therapy
Introduction
Silvia Ramirez is a prominent inventor based in Novato, California. She has made significant contributions to the field of gene therapy, particularly in the development of liver-targeting adeno-associated viral vectors. Her innovative work has the potential to advance therapeutic options for various liver-related diseases.
Latest Patents
Silvia Ramirez holds a patent for her invention titled "Liver targeting adeno-associated viral vectors." This invention relates to novel adeno-associated virus (AAV) capsid proteins, AAV particles comprising a novel capsid protein, polynucleotides encoding these capsid proteins, and AAV vectors expressing these capsid proteins. The invention also encompasses methods of making the described AAV vectors and their associated therapeutic uses. She has 1 patent to her name.
Career Highlights
Silvia is currently employed at BioMarin Pharmaceutical Inc., where she continues to work on groundbreaking research in gene therapy. Her role at the company allows her to collaborate with other experts in the field and contribute to the development of innovative treatments.
Collaborations
One of her notable coworkers is Peter Cameron Colosi, with whom she collaborates on various projects related to gene therapy and viral vector development.
Conclusion
Silvia Ramirez is a key figure in the advancement of liver-targeting gene therapy through her innovative inventions and collaborations. Her work at BioMarin Pharmaceutical Inc. exemplifies her commitment to improving therapeutic options for patients.